Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Epigentek Poised to Become Most Influential Epigenetic Player in Chromatin Immunoprecipitation (ChIP) Market
  • USA - English


News provided by

Epigentek Group Inc.

Apr 13, 2015, 16:50 ET

Share this article

Share toX

Share this article

Share toX

Epigentek's accurate and convenient chromatin immunoprecipitation (ChIP) kits address common issues faced by epigenetic researchers.
Epigentek's accurate and convenient chromatin immunoprecipitation (ChIP) kits address common issues faced by epigenetic researchers.

Farmingdale, NY (PRWEB) April 13, 2015 -- Epigentek, a biotech firm based in Farmingdale, New York, now offers epigenetic researchers the most comprehensive selection of convenient tools for conducting accurate chromatin immunoprecipitation (ChIP) experiments.

These ChIP kits use a convenient microplate-based format and are built specifically for low cell input, tissue input, plant input, or even all-in-one ChIP-seq library preparation.

Post this

Since 2005, Epigentek has been helping investigators carry out high quality, affordable, and publishable epigenetic research with their wide range of kits, antibodies, reagents, and instruments. Now, Epigentek has established their expansive repertoire of optimized ChIP products and services with the recent addition of two ChIP kits that focus on low cell input and streamlining ChIP-seq projects, thereby securing their position as a promising influential player in the chromatin immunoprecipitation (ChIP) market.

Chromatin immunoprecipitation is one of the most popular assays in epigenetic research used to investigate protein-DNA interactions in cells. In light of advancements in next-generation sequencing (NGS) technology, ChIP-seq can also be used in conjunction with chromatin IP to pinpoint a specific gene sequence to which a protein of interest binds on a significantly wider scale, helping investigators understand crucial cellular processes.

The company’s complete solutions for chromatin immunoprecipitation draws on over a decade of experience in epigenetic research and address a variety of demands and needs familiar to many researchers. Ranging from an extensive line of convenient microplate-based ChIP kits to comprehensive chromatin immunoprecipitation sequencing (ChIP-seq) and ChIP-qPCR services, Epigentek offers innovative and effective solutions for every step of a ChIP workflow.

After they debuted the first microplate-based ChIP format in 2005, the team at Epigentek resolved the throughput bottleneck that had long been hindering scientists’ ChIP experiments. Similarly, their 96-well plate based Pre-Sure™ kit for ChIP antibody validation, introduced in 2014, overcame issues many researchers face in regard to the highly variable and unreliable so-called “ChIP-grade” antibodies that saturate the market. Due to Epigentek’s proprietary method, researchers now quickly validate their antibodies for ChIP without having to carry out cumbersome ChIP-PCR or full-blown ChIP sequencing.

The growing biotech company continues to refine their epigenetic expertise with their extensive line of ChIP research kits that brings convenient, easy-to-use, and accurate tools to the lab. The company’s full line of microplate-based ChIP kits are specifically designed by a team of in-house scientists to overcome common demands and limitations faced by nearly all researchers, such as low cell numbers, turnaround time, and high throughput, next-generation sequencing compatibility. These ChIP kits use a convenient microplate-based format and are built specifically for low cell input, tissue input, plant input, or even all-in-one ChIP-seq library preparation.

Epigentek’s highly-cited classic ChIP kit for cell input is available to researchers looking to perform ChIP accurately, at rapid speeds, and with extraordinary consistency. The EpiQuik Chromatin Immunoprecipitation (ChIP) Kit uses a flexible microwell strip format and comes with a convenient bundle of ready-to-use essential components. This chromatin immunoprecipitation kit is suitable in combination with qualitative and quantitative PCR (qPCR), methylation specific PCR (MS-PCR), DNA sequencing, southern blot, and DNA microarray.

Optimized for researchers facing limitations with low cell numbers, the recently released ChromaFlash High-Sensitivity ChIP Kit enables scientists to perform high-throughput ChIP in a convenient microplate-based format using as few as 2,000 cells. The EpiQuik Tissue Chromatin Immunoprecipitation (ChIP) Kit is created specifically for researchers working with mammalian tissue input. For those using plant cells, the EpiQuik Plant ChIP Kit is made precisely for carrying out a successful chromatin immunoprecipitation from plant cells.

The EpiNext ChIP-Seq High-Sensitivity Kit (Illumina) expedites NGS-based experiments from start to finish for seamless integration into a researcher’s ChIP-seq workflow. This ChIP kit is first of its kind to conveniently package ChIP and ChIP-seq library preparation into one easy-to-use kit.

Adding to their repertoire of chromatin immunoprecipitation research tools, the company has also advanced DNA shearing and chromatin shearing technology with their high throughput line of sonication systems, including the multi-sample EpiSonic 2000 which enables researchers to consistently and reliably shear up to 12 samples to 300 bp in only 10 minutes.

Furthermore, Epigentek recently announced their chromatin analysis services including ChIP antibody validation, chromatin immunoprecipitation sequencing (ChIP-seq) and chromatin immunoprecipitation quantitative PCR (ChIP-qPCR) to provide researchers with accurate, publication-ready results.

Epigentek’s years of experience and their continued innovation in ChIP kit products and services over the past decade, including the recent addition of their high sensitivity ChIP and ChIP-seq kits, make this company poised to become one of the most influential players in the ChIP market.

For a comparison of all ChIP kits offered, readers can visit http://www.epigentek.com/chip

About Epigentek Group Inc.
Epigentek is a New York-based biotechnology company that focuses on developing and providing innovative technologies, services, and products as a complete and systematic solution for epigenetic related research and drug discovery. Visit the informative website at http://www.epigentek.com.

Bailey Kirkpatrick, Epigentek Group Inc., http://www.epigentek.com, +1 631-755-0888 Ext: 156, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.